PL311736A1 - Derivatives of 1h-imidazoles - Google Patents

Derivatives of 1h-imidazoles

Info

Publication number
PL311736A1
PL311736A1 PL95311736A PL31173695A PL311736A1 PL 311736 A1 PL311736 A1 PL 311736A1 PL 95311736 A PL95311736 A PL 95311736A PL 31173695 A PL31173695 A PL 31173695A PL 311736 A1 PL311736 A1 PL 311736A1
Authority
PL
Poland
Prior art keywords
imidazoles
derivatives
Prior art date
Application number
PL95311736A
Other languages
English (en)
Inventor
Jean-Pierre Geerts
Genevieve Motte
Edmond Differding
Jean-Pierre Henichart
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of PL311736A1 publication Critical patent/PL311736A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL95311736A 1994-12-14 1995-12-08 Derivatives of 1h-imidazoles PL311736A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9425211.1A GB9425211D0 (en) 1994-12-14 1994-12-14 Substituted 1H-imidazoles

Publications (1)

Publication Number Publication Date
PL311736A1 true PL311736A1 (en) 1996-06-24

Family

ID=10765918

Family Applications (1)

Application Number Title Priority Date Filing Date
PL95311736A PL311736A1 (en) 1994-12-14 1995-12-08 Derivatives of 1h-imidazoles

Country Status (26)

Country Link
US (1) US5658938A (en, 2012)
EP (1) EP0717037A1 (en, 2012)
JP (1) JPH08208622A (en, 2012)
KR (1) KR960022474A (en, 2012)
CN (1) CN1054376C (en, 2012)
AR (1) AR002257A1 (en, 2012)
AU (1) AU693614B2 (en, 2012)
BG (1) BG63043B1 (en, 2012)
BR (1) BR9505815A (en, 2012)
CA (1) CA2165133A1 (en, 2012)
CZ (1) CZ327195A3 (en, 2012)
EE (1) EE9500064A (en, 2012)
FI (1) FI955927A7 (en, 2012)
GB (1) GB9425211D0 (en, 2012)
HU (1) HUT73980A (en, 2012)
IL (1) IL116325A (en, 2012)
IS (1) IS4311A (en, 2012)
MX (1) MX9505063A (en, 2012)
NO (1) NO305316B1 (en, 2012)
NZ (1) NZ280646A (en, 2012)
PL (1) PL311736A1 (en, 2012)
RO (1) RO113346B1 (en, 2012)
RU (1) RU2156239C2 (en, 2012)
SK (1) SK155095A3 (en, 2012)
TW (1) TW303362B (en, 2012)
ZA (1) ZA9510554B (en, 2012)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
GB9520150D0 (en) 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
ZA981080B (en) * 1997-02-11 1998-08-12 Warner Lambert Co Bicyclic inhibitors of protein farnesyl transferase
US6503935B1 (en) * 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
US20030073850A1 (en) * 1998-08-07 2003-04-17 Altenbach Robert J. 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use
US6388090B2 (en) 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
JP2003532712A (ja) 2000-05-08 2003-11-05 オリオン コーポレーション α２アドレナリン作用活性を有する新規な多環式インダニルイミダゾール
TW200306783A (en) * 2002-04-29 2003-12-01 Fmc Corp Pesticidal heterocycles
US20040266776A1 (en) * 2003-06-25 2004-12-30 Gil Daniel W. Methods of preventing and reducing the severity of stress-associated conditions
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
FI20022159A0 (fi) * 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä
BRPI0707258A2 (pt) * 2005-01-27 2011-04-26 Hoffmann La Roche uso de 2-imidazóis para o tratamento de distúrbios de cns
ATE546437T1 (de) * 2006-10-19 2012-03-15 Hoffmann La Roche Aminomethyl-4-imidazole
JP5167265B2 (ja) * 2006-10-19 2013-03-21 エフ．ホフマン−ラ ロシュ アーゲー 微量アミン関連受容体に親和性を有するアミノメチル−２−イミダゾール
CN101535292A (zh) * 2006-11-02 2009-09-16 弗·哈夫曼-拉罗切有限公司 作为痕量胺相关受体的调节剂的取代的2-咪唑类化合物
MX2009005047A (es) * 2006-11-16 2009-05-25 Hoffmann La Roche 4-imidazoles sustituidos.
ES2364701T3 (es) * 2006-12-13 2011-09-12 F. Hoffmann-La Roche Ag Nuevos 2-imidazoles como ligandos para receptores asociados a aminas trazas.
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
KR101275405B1 (ko) * 2007-02-02 2013-06-17 에프. 호프만-라 로슈 아게 중추 신경계 장애의 치료용 ｔａａｒ1 리간드로서 2-아미노옥사졸린
JP2010518163A (ja) * 2007-02-13 2010-05-27 シェーリング コーポレイション 機能選択性α２Ｃアドレナリン受容体アゴニスト
RU2009134059A (ru) * 2007-02-13 2011-03-20 Шеринг Корпорейшн (US) Функционально селективные агонисты альфа2с адренорецептора
EP2142538B1 (en) * 2007-02-13 2011-10-26 Schering Corporation Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
JP5130305B2 (ja) * 2007-02-15 2013-01-30 エフ．ホフマン−ラ ロシュ アーゲー Ｔａａｒ１リガンドとしての２−アミノオキサゾリン
WO2009003868A2 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
JP2010531836A (ja) * 2007-07-03 2010-09-30 エフ．ホフマン−ラ ロシュ アーゲー ４−イミダゾリン及びそれらの抗うつ剤としての使用
WO2009016048A1 (en) * 2007-07-27 2009-02-05 F. Hoffmann-La Roche Ag 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands
BRPI0815038A2 (pt) * 2007-08-02 2015-03-17 Hoffmann La Roche Uso de derivados de benzamida para o tratamento de transtornos do cns
BRPI0814758A2 (pt) * 2007-08-03 2015-03-03 Hoffmann La Roche Piridinacarboxamida e derivados de benzamida como ligantes taar1
CL2008003553A1 (es) * 2007-12-05 2009-11-27 Grindeks Jsc Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
EP2257546B1 (en) 2008-02-21 2012-08-15 Merck Sharp & Dohme Corp. Functionally selective alpha2c adrenoreceptor agonists
JP5547187B2 (ja) * 2008-07-24 2014-07-09 エフ．ホフマン−ラ ロシュ アーゲー ４，５−ジヒドロ−オキサゾール−２−イル誘導体
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
EP2323734A1 (en) * 2008-08-04 2011-05-25 Schering Corporation Cyclopropylchromene derivatives as modulators of the alpha-2c receptor
EP2356106A1 (en) 2008-10-07 2011-08-17 Schering Corporation Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
US8673950B2 (en) 2010-11-02 2014-03-18 Hoffmann-Laroche Inc. Dihydrooxazol-2-amine derivatives
US8802673B2 (en) 2011-03-24 2014-08-12 Hoffmann-La Roche Inc Heterocyclic amine derivatives
US9073911B2 (en) 2011-06-09 2015-07-07 Hoffmann-La Roche Inc. Pyrazole derivatives
US9029370B2 (en) 2011-06-10 2015-05-12 Hoffmann-La Roche Inc. Substituted benzamide derivatives
ES2554843T3 (es) 2012-01-12 2015-12-23 F. Hoffmann-La Roche Ag Derivados heterocíclicos como receptores asociados de trazas de amina (TAARs)
MX363362B (es) 2012-09-14 2019-03-21 Hoffmann La Roche Derivados de pirazol carboxamida como moduladores de los receptores asociados con las aminas traza (taar) para uso en el tratamiento de varios trastornos, tales como depresión, diabetes y enfermedades de parkinson.
BR112015001771B1 (pt) 2012-09-17 2022-08-16 F. Hoffmann-La Roche Ag Derivados de carboxamida de triazol, seu uso e composição farmacêutica que os compreende
WO2015165085A1 (en) 2014-04-30 2015-11-05 F.Hoffmann-La Roche Ag Morpholin-pyridine derivatives
EP3186250B1 (en) 2014-08-27 2018-04-18 F.Hoffmann-La Roche Ag Substituted pyrazino[2,1-a]isoquinoline derivatives for the treatment of cns disorders
JP6539724B2 (ja) 2014-08-27 2019-07-03 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｔａａｒリガンドとしての置換アゼチジン誘導体
CN108777958B (zh) * 2016-03-17 2021-03-12 Fmc有限公司 将s-对映体转换成其消旋形式的方法
MX377836B (es) 2016-03-17 2025-03-11 Hoffmann La Roche Derivado de 5-etil-4-metil-pirazol-3-carboxamida teniendo actividad como agonista de receptor asociado con aminas trazas (taar).
CN116496261B (zh) * 2023-03-09 2025-06-27 中国人民解放军军事科学院军事医学研究院 4-(1h)-咪唑类衍生物及其医药用途
CN118684628B (zh) * 2024-05-20 2025-06-17 中国人民解放军军事科学院军事医学研究院 取代二氢茚基咪唑类化合物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6048972A (ja) * 1983-08-25 1985-03-16 Dai Ichi Seiyaku Co Ltd テトラヒドロナフタレン誘導体
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB8626287D0 (en) * 1986-11-04 1986-12-03 Ucb Sa Substituted 1h-imidazoles
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
US5151526A (en) * 1990-10-11 1992-09-29 The United States Of America As Represented By The Secretary Of The Army 4-[1-(1-naphthalenyl)ethyl]-1H-imidazole, method of making and use as an anesthetic
JPH04210680A (ja) * 1990-12-01 1992-07-31 Nissan Chem Ind Ltd イミダゾール誘導体および植物生長調節剤
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles

Also Published As

Publication number Publication date
RU2156239C2 (ru) 2000-09-20
CN1133837A (zh) 1996-10-23
IL116325A (en) 1999-10-28
SK155095A3 (en) 1997-02-05
EP0717037A1 (fr) 1996-06-19
US5658938A (en) 1997-08-19
RO113346B1 (ro) 1998-06-30
FI955927L (fi) 1996-06-15
NZ280646A (en) 1996-08-27
BG100208A (bg) 1996-07-31
AU693614B2 (en) 1998-07-02
CZ327195A3 (en) 1996-07-17
GB9425211D0 (en) 1995-02-15
BR9505815A (pt) 1998-01-06
CN1054376C (zh) 2000-07-12
IL116325A0 (en) 1996-03-31
EE9500064A (et) 1996-06-17
IS4311A (is) 1996-06-15
FI955927A7 (fi) 1996-06-15
NO955034D0 (no) 1995-12-12
MX9505063A (es) 1997-01-31
KR960022474A (ko) 1996-07-18
JPH08208622A (ja) 1996-08-13
ZA9510554B (en) 1996-06-13
AU4036895A (en) 1996-06-20
FI955927A0 (fi) 1995-12-11
AR002257A1 (es) 1998-03-11
HUT73980A (en) 1996-10-28
TW303362B (en, 2012) 1997-04-21
NO305316B1 (no) 1999-05-10
BG63043B1 (bg) 2001-02-28
CA2165133A1 (en) 1996-06-15
HU9503549D0 (en) 1996-02-28
NO955034L (no) 1996-06-17

Similar Documents

Publication Publication Date Title
PL311736A1 (en) Derivatives of 1h-imidazoles
PL329875A1 (en) Derivatives of carbolin
PL329195A1 (en) Derivatives of 6-phenylpyridol-2-amine
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
PL313619A1 (en) Derivatives of piperydine
PL310443A1 (en) Derivatives of pyrolo-pyridine
PL339551A1 (en) Derivatives of rezorcin
ZA952413B (en) 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
PL327998A1 (en) Novel derivatives of 19-nor-pregnene
ZA955759B (en) Acyl derivatives of azolones
GB9511077D0 (en) 17B-Substituted-6-azasteroid derivatives
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
PL306127A1 (en) Derivatives of epi-epibathydine
ZA953356B (en) Benzocycloalkylazolethione derivatives
EP0692482A3 (en) 1-pyridyltetrazolinone derivatives
GB2295614B (en) Novel 5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinylbenzimidazole derivatives
PL312692A1 (en) New derivatives of dialkoxy-pyridinol-benzimidazole
ZA955753B (en) Heterocyclic derivatives of azolones
IL112519A0 (en) 5-heteroarylindole derivatives
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
HU9700071D0 (en) Use of muramilpeptides
PL334769A1 (en) Derivatives of 5-aroylnaphtene
HU9503582D0 (en) Thienopyridon derivatives
GB9511365D0 (en) Pyridazino-indole derivatives
IL108595A0 (en) Novel derivatives of tetramethylcyclopropane